Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Virology Interest Group Committee, Work group, Advisory group, or Task Force FDA NCI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NINDS The Virology Interest Group comprises researchers at National Institutes of Health (NIH) and in the local area who are interested in virology. The group organizes activities designed to promote interactions and exchange information.
Vision Research Collaborative Research Initiative FDA NEI The Vision Research Collaborative (VRC) is a joint initiative between the National Eye Institute (NEI) and the Congressionally Directed Medical Research Programs (CDMRP) Vision Research Program (VRP) of the Department of Defense (DOD). The goal of this partnership is to provide additional funding opportunities for VRP proposals, enhance current NEI Program portfolios, expand the scope of research supported by the NEI, and provide support for high quality projects addressing critical gaps in civilian and military vision research.
White House Gender Policy Council: Science & Technology Interagency Working Group Committee, Work group, Advisory group, or Task Force OASH, FDA NICHD, NCI White House led interagency group on gender policy in science ; technology
WHO Nuturing Care Framework Advisory Group Committee, Work group, Advisory group, or Task Force CDC NICHD International advisory group led by the WHO with dozens of international partnering agencies.
WHO Risk Assessment Netword Public Education Campaign CDC NIEHS International communication, education, collaboration. Several workgroups, workproducts, and international meetings.
Why has progress in hypertension control plateaued in the United States, and how can progress be restarted? Establishing a Research Agenda for the 2020 Meeting/ Workshop CDC NHLBI Workshop to develop a research agenda for Centers for Disease Control and Prevention (CDC) and National Heart, Lung, and Blood Institute (NHLBI).
Working Groups to Develop HIV/AIDS Treatment and Prevention Guidelines Committee, Work group, Advisory group, or Task Force OASH OD/DPCPSI/OAR, CC, NIAID, NICHD, NLM, OD/DPCPSI There are five Office of AIDS Research Advisory Council (OARAC) Working Groups to maintain updated federally approved medical practice guidelines for HIV/AIDS Treatment and the Prevention of HIV Transmission from Mother to Infant. The five working groups are the 1) Panel on Antiretroviral Guidelines for Adults and Adolescents, 2) Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 3) Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV, 4) Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children, and 5) Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. The HIV/AIDS Treatment and Prevention Guideline Panels update guidelines for HIV/AIDS care providers with the most current information on combination antiretroviral therapy, treatment and prevention of opportunistic infections for people with HIV; the prevention of HIV transmission from an infected mother to her infant; and the safety and efficacy of HIV/AIDS therapies.
World Cancer Research Day, HPVAware, and World No Tobacco Day, World Cancer Day observances Public Education Campaign OGA, ASPA NCI, FIC The National Cancer Institute (NCI) Office of Communications and Public Liaison and Center for Global Health collaborate with the Department of Health and Human Services (DHHS) Assistant Secretary for Public Affairs Digital Media Office to coordinate public education campaigns featuring digital materials that highlight prevention promotion and wellness programs. These materials are shared across all HHS Operating Divisions (OPDIVs).
World Health Organization (WHO) Programme on Prevention of Deafness and Hearing Loss Committee, Work group, Advisory group, or Task Force CDC NIDCD NIDCD is a founding member of WHO’s World Hearing Forum, a global network of stakeholders promoting ear and hearing care worldwide. Members work, in part, to facilitate implementation of the World Health Assembly resolution on Prevention of Deafness and Hearing Loss. The resolution called on WHO to develop a World Report on Hearing; NIDCD has supported the development of this report – the first of its kind – via a contract mechanism and subject matter expertise via stakeholders’ meetings.
World Health Organization Pediatric Antiretroviral Drug Optimization (PADO) Committee, Work group, Advisory group, or Task Force CDC, FDA NICHD WHO-led drug optimization activities are designed to promote broad access to more efficacious, safer and more tolerable antiretroviral (ARV) regimens in optimal formulations for adults, adolescents, children, and pregnant and lactating women.